Heit J, Hoffman R S, Goldfrank L R
New York University School of Medicine, USA.
Acad Emerg Med. 1994 Sep-Oct;1(5):438-42. doi: 10.1111/j.1553-2712.1994.tb02523.x.
To evaluate the effects of an antiarrhythmic dose of lidocaine on cocaine-induced ataxia, seizures, and death in mice.
A randomized, controlled, blinded investigation was conducted using 220 female Swiss albino mice. Groups of 20 animals received intraperitoneal (IP) administration of either 31.6 mg/kg of lidocaine hydrochloride in 0.9% NaCl (ten animals) or an equal volume of 0.9% NaCl solution (ten animals). After 5 minutes, all the animals received IP cocaine in incremental doses ranging from 40 to 110 mg/kg. The animals were observed for ataxia, seizures, and death. The animals pretreated with lidocaine were compared with the control animals for the number of adverse effects from cocaine at each dose tested.
Lidocaine significantly increased the overall incidences of cocaine-induced ataxia (p = 0.02) and seizures (p < 0.001). However, pretreatment with lidocaine offered protection against cocaine lethality (p < 0.0001).
In this preexposure model, lidocaine protects mice against cocaine-induced lethality. These effects seem to be independent of convulsive activity. Further study is required to determine the safety and efficacy of lidocaine for the management of cocaine-induced arrhythmias.
评估抗心律失常剂量的利多卡因对可卡因诱导的小鼠共济失调、癫痫发作和死亡的影响。
使用220只雌性瑞士白化小鼠进行了一项随机、对照、双盲研究。20只动物为一组,分别腹腔注射(IP)0.9%氯化钠中的31.6毫克/千克盐酸利多卡因(10只动物)或等体积的0.9%氯化钠溶液(10只动物)。5分钟后,所有动物接受递增剂量(40至110毫克/千克)的腹腔注射可卡因。观察动物的共济失调、癫痫发作和死亡情况。将用利多卡因预处理的动物与对照动物在每个测试剂量下可卡因产生的不良反应数量进行比较。
利多卡因显著增加了可卡因诱导的共济失调(p = 0.02)和癫痫发作(p < 0.001)的总体发生率。然而,利多卡因预处理可预防可卡因致死性(p < 0.0001)。
在这个预先暴露模型中,利多卡因可保护小鼠免受可卡因诱导的致死性。这些作用似乎与惊厥活动无关。需要进一步研究以确定利多卡因治疗可卡因诱导的心律失常的安全性和有效性。